News & Noteworthy
CSL Behring Presents Data on Therapeutic Potential of Idelvion: CSL Behring recently reported new results from its phase III clinical development program designed to evaluate Idelvion®. The findings were presented at the 58th Annual Meeting of the American Society of Hematology (ASH), held December 3-6, 2016, in San Diego, CA. Read More
Tretten, Novo Nordisk's Recombinant Therapy for Congenital Factor XIII A-subunit deficiency, Available Through BDI Pharma: Learn More
Cloud-based DSCSA Portal Available for BDI Pharma Customers: Customers now can receive and access all required transaction data from BDI Pharma via electronic portal. Read More
Quality Customer Service
BDI Representatives are on-call for your emergency and after-hours needs. Call 1-800-948-9834 for more information or to place an order today.
Any time I need an emergency delivery, they get it here as quickly as possible – they will stop at nothing. I’m very happy with what we have right now with BDI and how they provide for us.
Hospital Inpatient Pharmacy Buyer
Other distributors don’t seem to have the same level of concern for the overall outcomes of our patients as BDI Pharma does.
Specialty Pharmacy Manager
We encounter a lot of dishonesty in this industry, so credibility and honesty is definitely something BDI Pharma can hang their hat on.
Hospital Pharmacy Manager